- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01367392
Effectiveness and Safety of CT-guided Needle Placement in the Liver With the Aid of the ActiSight Needle Guidance System
February 14, 2012 updated by: ActiViews Ltd.
Confirmation of Clinical Effectiveness and Safety of CT-guided Needle Placement in the Liver With the Aid of the ActiSight Needle Guidance System
The purpose of this study is to confirm the safety and effectiveness of the ActiSight™ Needle Guidance System with CT-guided percutaneous (through the skin) liver biopsies and ablations .
The device used in this study is designed to assist the physician in guiding the needle towards the suspected area.
This device does not change the procedure of liver biopsy or ablation.
The only difference is that a small adhesive pad is placed on the skin and a miniature video camera is attached to the end of the needle.
This camera does not enter the body.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada
- Royal Victoria Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or non-pregnant female subjects, between the ages of 18 and 80 at the time of enrollment.
- Subjects scheduled for clinically indicated CT guided percutaneous needle placements in the liver who meet the desired target population described above.
- Written informed consent to participate in the study.
- Ability to comply with the requirements of the study procedures.
- Verified home address and phone number to facilitate study follow-up.
Exclusion Criteria:
- Significant coagulopathy that cannot be adequately corrected.
- Subjects who participated in an active stage of any drug, intervention or treatment trial within 30 days of enrollment.
- Subjects with preexisting conditions, which, in the opinion of the investigator, interfere with the conduct of the study.
- Subjects who are uncooperative or cannot follow instructions.
- Mental state that may preclude completion of the study procedure.
- Pregnant or nursing female subjects.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: interventional procedure
The patients undergo the required interventional procedure, biopsy or ablation
|
biopsy or ablation performed as in standard of care with assistance of ActiSight Needle Guidance system
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
accuracy
Time Frame: during the procedure
|
Frequency of placing the needle at a location suitable for the planned intervention, as determined by the investigator reviewing the CT images.
|
during the procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
time
Time Frame: during the procedure
|
Total CT-Guided procedure time, starting with scan for entry point planning;
|
during the procedure
|
time
Time Frame: during the procedure
|
Time required to guide the needle to the target
|
during the procedure
|
radiation
Time Frame: during the procedure
|
Subject radiation exposure during the procedure
|
during the procedure
|
total number of scans
Time Frame: during the procedure
|
Number of CT scans during the procedure
|
during the procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2011
Primary Completion (Actual)
January 1, 2012
Study Completion (Actual)
January 1, 2012
Study Registration Dates
First Submitted
June 6, 2011
First Submitted That Met QC Criteria
June 6, 2011
First Posted (Estimate)
June 7, 2011
Study Record Updates
Last Update Posted (Estimate)
February 15, 2012
Last Update Submitted That Met QC Criteria
February 14, 2012
Last Verified
February 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- ACST-2011-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Accurate Navigation to the Lesion
-
Regentis BiomaterialsUnknownCartilage Lesion to the Femoral Condyle
-
Methodist Health SystemRecruitingIdentify More Accurate Predictive Models of Transplant Risk to Monitor and Evaluate New and Existing Patient FactorsUnited States
-
CellCoTec B.V.CompletedArticular Cartilage Lesion of the KneeBelgium, Poland, United Kingdom
-
Fundacion para la Investigacion Biomedica del Hospital...UnknownArticular Cartilage Lesion of the Femoral CondyleSpain
-
BG UnfallklinikUnknownTraumatic Lesion of Sensory Nerves of the HandGermany
-
Columbus Regional HealthCompletedLung Mass | Lung Nodule | Lesion of the LungUnited States
-
Tel-Aviv Sourasky Medical CenterCompletedConsecutive Subjects Who Are Suitable for a Coronary | Angioplasty of de Novo Lesion(s) in Native Coronary | Arteries Should be Screened for Eligibility. | A Total Number of 200 Patients Fulfilling the Selection | Criteria and Willing to Sign the Informed Consent Should | be Enrolled in the...Israel
-
Biosolution Co., Ltd.Ewha Womans University; Gangnam Severance Hospital; Severance Hospital; Kyunghee...CompletedArticular Cartilage Lesion of the Knee
-
Nova Scotia Health AuthorityCompletedTime it Takes to Successfully Intubate the Patient With the GlideScope | Time to Intubate Between the Two ViewsCanada
Clinical Trials on biopsy or ablation
-
Mauna Kea TechnologiesCompletedLung Percutaneous Biopsy | Liver Percutaneous BiopsyFrance
-
Clear Guide MedicalUniversity of MarylandWithdrawn
-
Clear Guide MedicalJohns Hopkins UniversityWithdrawn
-
Ping LiangRecruitingHepatocellular Carcinoma | Surgery | Ablation | Prognosis | Contrast-enhanced UltrasoundChina
-
Chinese University of Hong KongThe Hong Kong Society of GastroenterologyCompletedHepatocellular CarcinomaHong Kong
-
Royal Brompton & Harefield NHS Foundation TrustBaylis Medical CompanyUnknownAtrial Tachycardia | AF - Atrial FibrillationUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisCompletedHepatocellular CarcinomasFrance
-
The Second Hospital of Hebei Medical UniversityCompletedAtrial FibrillationChina
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Duke UniversityCompleted